Tic Toc smile and wave.., page-32

"Can you show me where they stats that and also literature as to what would the advantage be?"

Hey Swami, I corrected your misspell and was feeling generous, so decided to do the research for you. Can't see any real advantage of testing for I vs T short of T apparently has the habit of throwing a false-positive... Wait. That would be a pretty big advantage (I think)...

"The main difference between troponins I and T is that cardiac troponin I tests measure only cardiac troponin; tests for cardiac troponin T may cross-react with troponin found in other muscles and give positive or increased results in the absence of heart damage."

http://medical-dictionary.thefreedictionary.com/Troponins Test

From the Philips website confirming Troponin I:
"..Based on its proprietary Magnotech biosensor technology, the Minicare handheld diagnostic test can perform a wide variety of assays including hormones, drugs and proteins. The platform allows multiplexing capabilities making it possible to test for multiple markers from the same droplet of blood at the same time. The first application for acute care is cTnI (cardiac Troponin I). Philips aims to offer a full range of markers for the acute care setting.."

From the same article referring to the Minicare platform
"What is innovative about it?
· Breakthrough innovation in biosensor nanotechnology Magnotech invented by Philips: All assay reagents are located in the disposable cartridge. The entire assay process within the cartridge is executed by controlled movement of the magnetic nanoparticles within the cartridge using magnetic fields. After a short incubation stage the amount of bound nanoparticles are detected optically.
· Smart technology, at the point of care: results within minutes, lab-equivalent accuracy, small sample volume, easy to use, requires minimal training only. High robustness and reliability is ensured by the absence of moving parts in the system.
· State-of-the art connectivity: integration of test results with clinical patient information available in the electronic patient file.
· Open platform model enables partners to expand test menu in healthcare. Moreover, the technology is not limited to healthcare and opens opportunities in pharma, food analysis, and veterinary care."

http://www.newscenter.philips.com/p...eet-Inside-innovation-Minicare-Acute-Care.pdf

Guess that's about it.